Literature DB >> 23634253

Cyclins and cell cycle control in cancer and disease.

Mathew C Casimiro1, Marco Crosariol, Emanuele Loro, Zhiping Li, Richard G Pestell.   

Abstract

Cyclin D1 overexpression is found in more than 50% of human breast cancers and causes mammary cancer in transgenic mice. Dysregulation of cyclin D1 gene expression or function contributes to the loss of normal cell cycle control during tumorigenesis. Recent studies have demonstrated that cyclin D1 conducts additional specific functions to regulate gene expression in the context of local chromatin, promote cellular migration, and promote chromosomal instability. It is anticipated that these additional functions contribute to the pathology associated with dysregulated cyclin D1 abundance. This article discusses evidence that examines the functional roles that cyclin D1 may play in cancer with an emphasis on other cyclin family members that also may contribute to cancer and disease in a similar fashion.

Entities:  

Keywords:  CIN; cyclin D1; cyclins; migration; stem cells

Year:  2012        PMID: 23634253      PMCID: PMC3636749          DOI: 10.1177/1947601913479022

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  169 in total

1.  Cyclin G1 overcomes radiation-induced G2 arrest and increases cell death through transcriptional activation of cyclin B1.

Authors:  H R Seo; D H Lee; H J Lee; M Baek; S Bae; J W Soh; S J Lee; J Kim; Y S Lee
Journal:  Cell Death Differ       Date:  2005-12-02       Impact factor: 15.828

2.  Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression.

Authors:  M C Horne; G L Goolsby; K L Donaldson; D Tran; M Neubauer; A F Wahl
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

3.  A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.

Authors:  Siwanon Jirawatnotai; Yiduo Hu; Wojciech Michowski; Joshua E Elias; Lisa Becks; Frederic Bienvenu; Agnieszka Zagozdzon; Tapasree Goswami; Yaoyu E Wang; Alan B Clark; Thomas A Kunkel; Tanja van Harn; Bing Xia; Mick Correll; John Quackenbush; David M Livingston; Steven P Gygi; Piotr Sicinski
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

4.  A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

Authors:  Scott L Carter; Aron C Eklund; Isaac S Kohane; Lyndsay N Harris; Zoltan Szallasi
Journal:  Nat Genet       Date:  2006-08-20       Impact factor: 38.330

Review 5.  Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor-chemotherapy combinations as an anticancer strategy for solid tumors.

Authors:  Neil Johnson; Geoffrey I Shapiro
Journal:  Expert Opin Ther Targets       Date:  2010-11       Impact factor: 6.902

6.  Expression and activity of p40MO15, the catalytic subunit of cdk-activating kinase, during Xenopus oogenesis and embryogenesis.

Authors:  A J Brown; T Jones; J Shuttleworth
Journal:  Mol Biol Cell       Date:  1994-08       Impact factor: 4.138

7.  Cyclin E, a potential prognostic marker for breast cancer.

Authors:  K Keyomarsi; N O'Leary; G Molnar; E Lees; H J Fingert; A B Pardee
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

8.  An evolutionarily conserved cyclin homolog from Drosophila rescues yeast deficient in G1 cyclins.

Authors:  P Léopold; P H O'Farrell
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

Review 9.  The DNA damage response and cancer therapy.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

10.  Cyclin A is required at two points in the human cell cycle.

Authors:  M Pagano; R Pepperkok; F Verde; W Ansorge; G Draetta
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  82 in total

1.  Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors.

Authors:  Myrna Hurtado; Umesh T Sankpal; Aboubacar Kaba; Shahela Mahammad; Jaya Chhabra; Deondra T Brown; Raj K Gurung; Alvin A Holder; Jamboor K Vishwanatha; Riyaz Basha
Journal:  Cell Physiol Biochem       Date:  2018-11-30

2.  NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2.

Authors:  Donglin Ding; Huixing Huang; Quanfu Li; Wenbo Yu; Chenji Wang; Haijie Ma; Jiaxue Wu; Yongjun Dang; Long Yu; Wei Jiang
Journal:  Cell Death Discov       Date:  2020-01-22

3.  ComplexBrowser: A Tool for Identification and Quantification of Protein Complexes in Large-scale Proteomics Datasets.

Authors:  Wojciech Michalak; Vasileios Tsiamis; Veit Schwämmle; Adelina Rogowska-Wrzesińska
Journal:  Mol Cell Proteomics       Date:  2019-08-25       Impact factor: 5.911

4.  Association of CHEK2 polymorphisms with the efficacy of platinum-based chemotherapy for advanced non-small-cell lung cancer in Chinese never-smoking women.

Authors:  Wen Xu; Di Liu; Yang Yang; Xi Ding; Yifeng Sun; Baohong Zhang; Jinfu Xu; Bo Su
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

5.  Selective repression of the Drosophila cyclin B promoter by retinoblastoma and E2F proteins.

Authors:  Rima Mouawad; Pamela Himadewi; Dhruva Kadiyala; David N Arnosti
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2020-04-08       Impact factor: 4.490

6.  New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.

Authors:  Samar H Abbas; Amer Ali Abd El-Hafeez; Mai E Shoman; Monica M Montano; Heba A Hassan
Journal:  Bioorg Chem       Date:  2018-11-02       Impact factor: 5.275

Review 7.  Mechanisms of genome instability induced by RNA-processing defects.

Authors:  Yujia A Chan; Philip Hieter; Peter C Stirling
Journal:  Trends Genet       Date:  2014-05-01       Impact factor: 11.639

8.  Establishing cut-off points with clinical relevance for bcl-2, cyclin D1, p16, p21, p27, p53, Sox11 and WT1 expression in glioblastoma - a short report.

Authors:  Emma Camacho-Urkaray; Jorge Santos-Juanes; Francisco Borja Gutiérrez-Corres; Beatriz García; Luis M Quirós; Isabel Guerra-Merino; José Javier Aguirre; Iván Fernández-Vega
Journal:  Cell Oncol (Dordr)       Date:  2017-12-07       Impact factor: 6.730

Review 9.  Cancer stem cells: Regulation programs, immunological properties and immunotherapy.

Authors:  Dingxiao Zhang; Dean G Tang; Kiera Rycaj
Journal:  Semin Cancer Biol       Date:  2018-05-09       Impact factor: 15.707

10.  Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.

Authors:  Naoshad Muhammad; Sourav Bhattacharya; Robert Steele; Nancy Phillips; Ratna B Ray
Journal:  Clin Cancer Res       Date:  2016-12-13       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.